Confirmed Control Closed Transaction verified CPGMedical AestheticsProfessional SkincareSkincare
Obagi Medical Products Business acquired by Haitong International Zhonghua Finance Acquisition Fund I, L.P.
Haitong International Zhonghua Finance Acquisition Fund I, L.P. acquired Obagi Medical Products Business, a skincare brand on Jul 1, 2017. FundComb records estimated consideration of USD 190m. The current comp implies EV / revenue of 2.2x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Obagi Medical Products Business
- Acquirer
- Haitong International Zhonghua Finance Acquisition Fund I, L.P.
- Seller
- Valeant Pharmaceuticals
- Announced
- 2017-07-01
- Geography
- -
- Tags
- CPGMedical AestheticsProfessional SkincareSkincare
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-15
- Latest update
- 2026-06-15
Value and multiples
Price / value
USD 190M
Transaction value | USD
Basis: FundComb estimate
EV / revenue
2.2x
Period not stated
Basis: FundComb estimate
EV / EBITDA
6.3x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- USD 190m transaction value is a FundComb estimate. Public sources reviewed confirm the transaction, but do not independently disclose every valuation input.
- Implied EV / revenue is 2.2x, calculated from USD 190m value and USD 86.0m revenue.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- Implied EV / EBITDA is 6.3x, calculated from USD 190m value and USD 30.0m EBITDA.
Source summary
No public source summary has been published for this transaction yet.